Log in  First Connection?

Oncology ImagingArchives

Integrative multi-region MRI radiomics and clinical nomogram for preoperative lymphovascular invasion prediction in rectal cancer: a multicenter validation

 Published on 27/01/2026 |  Original article (Full-text)  | Chen Tianxian et al. | BMC Medical Imaging 2025; 26(1): 48

Colorectal cancer is the third most common malignancy worldwide, with a continuously rising incidence, particularly in younger populations under 50 years of age [1]. Lymphovascular invasion (LVI) denotes the pathological process whereby malignant tumor cells infiltrate into blood vessels and/or lymphatic...

CD31-associated vascular phenotyping using Doppler ultrasound and dual-energy CT for recurrence risk stratification in papillary thyroid cancer

 Published on 20/01/2026 |  Original article (Full-text)  | Zhou Yan et al. | Cancer imaging 2025; 26(1): 6

Papillary thyroid carcinoma (PTC) is generally associated with a favorable prognosis. However, a subset of patients experiences recurrence, leading to clinical challenges and the need for more intensive management [1, 2–3]. Accurate identification of patients at high risk of recurrence is clinically...

Modulating tumor interstitial fluid pressure using ultrasound and microbubble therapy: a preclinical study for enhanced drug delivery in cancer treatment

 Published on 13/01/2026 |  Original article (Full-text)  | Chen Liping et al. | BMC Cancer 2025; 26(1): 40

Cancer remains one of the leading causes of death worldwide, accounting for approximately one-sixth of all deaths [1]. In 2022, there were an estimated 20 million new cancer cases and 9.7 million cancer-related deaths globally. By 2050, the global cancer incidence is projected to exceed 35 million cases,...

Postoperative early recurrence prediction of pancreatic cancer based on CT and pathomics

 Published on 06/01/2026 |  Original article (Full-text)  | Cao Wei et al. | BMC Gastroenterology 2025; 25(1): 894

PDAC, representing approximately 85% of pancreatic malignancies, ranks among the most lethal solid tumors with a 5-year survival rate below 10%. Surgical resection is the only curative treatment for this disease [1, 2, 3–4]. Although surgical resection remains the sole curative option, over 80%...

Oncology Imaging
 NaN min.

 Published on 14/11/2024 |  Original article (Full-text)  |